Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
- 1 March 2003
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 967 (1-2) , 152-160
- https://doi.org/10.1016/s0006-8993(02)04243-9
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- The reduction of NADH: Ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's diseaseLife Sciences, 2001
- Alteration of Caspases and Apoptosis-Related Proteins in Brains of Patients with Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 2001
- Identification, Characterization, and Crystal Structure of the Omega Class Glutathione TransferasesJournal of Biological Chemistry, 2000
- AOP2 (Antioxidant Protein 2): Structure and Function of a Unique Thiol-Specific AntioxidantAntioxidants and Redox Signaling, 1999
- From Cytoprotection to Tumor Suppression: The Multifactorial Role of PeroxiredoxinsAntioxidants and Redox Signaling, 1999
- Oxidation of Cytosolic Proteins and Expression of Creatine Kinase BB in Frontal Lobe in Different Neurodegenerative DisordersDementia and Geriatric Cognitive Disorders, 1999
- Provisional clinical and neuroradiological criteria for the diagnosis of Pick's diseaseEuropean Journal of Neurology, 1998
- Murine Thioredoxin Peroxidase Delays Neuronal Apoptosis and Is Expressed in Areas of the Brain Most Susceptible to Hypoxic and Ischemic InjuryDNA and Cell Biology, 1997
- The Biology of Oxygen RadicalsScience, 1978
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976